论文部分内容阅读
目的探讨心脏手术后新发快速心房颤动临床治疗方法及应用效果。方法 14例心脏手术后新发快速心房颤动患者均给予胺碘酮治疗,记录其临床疗效。结果 14例心脏手术后新发快速心房颤动患者经相应措施治疗后均成功转为窦性心律,胺碘酮推注次数1~3次、平均(1.71±0.11)次,发病至窦性心律转复时间1~5 d、平均(2.47±0.21)d,转至窦性心律前无低血压、心动过缓等异常情况发生。14例患者中无脑梗死、死亡等严重后果发生,治疗有效率高达100.00%。结论尽早确诊并给予积极治疗是保障心脏手术后新发快速心房颤动患者疗效及预后的关键因素,临床医生应准确掌握心脏手术后新发快速心房颤动临床特点,接诊后准确诊断及采取有效治疗,有利于保障患者疗效及生活质量。
Objective To explore the clinical treatment of new-onset atrial fibrillation after cardiac surgery and its clinical application. Methods Amiodarone was given to 14 patients with newly diagnosed rapid atrial fibrillation after cardiac surgery and the clinical efficacy was recorded. Results Fourteen patients with new-onset atrial fibrillation after cardiac surgery were successfully converted to sinus rhythm after treatment. Amiodarone bolus was given 1 to 3 times (mean, 1.71 ± 0.11), with onset of sinus arrhythmia Complex time 1 ~ 5 d, mean (2.47 ± 0.21) d, before going to sinus rhythm no hypotension, bradycardia and other abnormalities occurred. 14 patients without cerebral infarction, death and other serious consequences occurred, the treatment efficiency up to 100.00%. Conclusion Early diagnosis and positive treatment are the key factors to ensure the efficacy and prognosis of patients with new-onset AF after cardiac surgery. Clinicians should accurately grasp the clinical features of new-onset AF after cardiac surgery. After diagnosis, accurate diagnosis and effective treatment should be taken , Is conducive to ensuring patient efficacy and quality of life.